Table 1.

Monoclonal antibody infusion process logistics and timing metrics from the 3 National Disaster Medical System-supported infusion sites and related strengths and challenges to inform implementation

Logistics and timing metrics	Site 1	Site 2	Site 3	Implementation considerations
				Strengths	Challenges
Infusion site type	Walk-up tent infusion site	Appointment-based outpatient infusion site	Appointment-based tent infusion site	Walk-up sites were beneficial in communities with low health care. system engagement Appointment-based sites facilitated batch preparation of monoclonal antibody infusion doses, shortening the overall time of the appointment. 30-minute staggering between patient group arrivals improved patient flow due to 15- to 30-minute intake process.	Walk-up sites exhibited longer wait times for on-demand pharmacy preparation of the monoclonal antibody. Batch preparation of monoclonal antibodies resulted in unused doses for walk-up systems. Walk-up site had large variability in timing due to confirming the patient’s SARS-CoV-2 positivity upon arrival. Appointment-based sites required increased staffing and planning to schedule patients.
Process type	Emergency medical visit	Outpatient infusion procedure	Outpatient infusion procedure
Infusion site start date	Dec 30, 2020	Jan 7, 2021	Jan 8, 2021
Total patients infused during study period (Start-Feb 26 2021)	397	824	402
Average rate (patients/day)	7	16	8
Most significant logistics barriers	Confirming SARS-CoV-2 patient positivity criteria	Coordination with pharmacy for monoclonal antibody preparation	Coordination with pharmacy for monoclonal antibody preparation
	Coordination with pharmacy for monoclonal antibody preparation	Staffing needs for scheduling process	Staffing needs for scheduling process
Hours of operation	24 hours/day	Monday-Friday	Monday-Friday
	7 days a week	9:00 am-5:00 pm	9:00 am-5:00 pm